Online Only Articles

Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia

Dept. Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic;CEITEC - Central European Institute of Technology, Masaryk University Brno, Brno, Czech Republic
Dept. Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic
3rd Dept. Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
Institute of Biostatistics and Analyses, Masaryk University Brno, Brno, Czech Republic
Dept. Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic
Dept. Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic
Dept. Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic
Department of Clinical Biochemistry, University Hospital Brno, Brno, Czech Republic
3rd Dept. Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
Dept. Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic;CEITEC - Central European Institute of Technology, Masaryk University Brno, Brno, Czech Republic
Vol. 98 No. 10 (2013): October, 2013 https://doi.org/10.3324/haematol.2013.086355